Back to UBS Group AG UBS Group AG

SRPTSRPT
29 quarters

Position history for UBS Group AGUBS Group AG's holdings in SAREPTA THERAPEUTICS INC

UBS Group AG holds 2.2M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $48.6M as of 2026-Q1. The position was increased (+8.4% shares). SRPT represents 0.0% of UBS Group AG's portfolio.

Current Value

$48.6M

Current Shares

2.2M

Total Value Change

+$39M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.2M
+8.4%
$48.6M0.0%$15.87
32
2025-Q4
Increased
2.1M
+3.4%
$44.3M0.0%$21.49
30
2025-Q3
Increased
2M
+297.2%
$38.4M0.0%$18.82
47
2025-Q2
Decreased
501,084
-65.4%
$8.6M0.0%$17.11
0
2025-Q1
Decreased
1.4M
-2.3%
$92.3M0.0%$70.41
0
2024-Q4
Increased
1.5M
+306.4%
$180M0.0%$121.19
49
2024-Q3
Increased
364,172
+3.8%
$45.5M0.0%$124.53
30
2024-Q2
Increased
350,764
+26.5%
$55.4M0.0%$158.00
36
2024-Q1
Increased
277,190
+0.3%
$35.9M0.0%$129.46
29
2023-Q4
Increased
276,276
+21.2%
$26.6M0.0%$96.43
34
2023-Q3
Increased
227,871
+5.3%
$27.6M0.0%$121.22
30
2023-Q2
Increased
216,340
+11.3%
$24.8M0.0%$112.24
32
2023-Q1
Increased
194,422
+19.5%
$26.8M0.0%$136.03
34
2022-Q4
Increased
162,680
+130.0%
$21.1M0.0%$129.58
46
2022-Q3
Decreased
70,738
-39.5%
$7.8M0.0%$109.63
0
2022-Q2
Decreased
116,938
-23.5%
$8.8M0.0%$77.07
0
2022-Q1
Increased
152,873
+144.0%
$11.9M0.0%$78.59
45
2021-Q4
Increased
62,644
+34.0%
$5.6M0.0%$90.59
35
2021-Q3
Increased
46,731
+37.7%
$4.3M0.0%$88.77
35
2021-Q2
Decreased
33,935
-61.1%
$2.6M0.0%$78.82
0
2021-Q1
Increased
87,200
+21.5%
$6.5M0.0%$73.10
33
2020-Q4
Increased
71,750
+7.3%
$12.2M0.0%$171.54
30
2020-Q3
Increased
66,855
+3.1%
$9.4M0.0%$141.28
28
2020-Q2
Decreased
64,865
-22.5%
$10.4M0.0%$162.71
0
2020-Q1
Decreased
83,664
-3.8%
$8.2M0.0%$98.52
0
2019-Q4
Decreased
86,979
-55.5%
$11.2M0.0%$128.79
0
2019-Q3
Increased
195,231
+78.5%
$14.7M0.0%$75.00
43
2019-Q2
Increased
109,361
+36.0%
$16.6M0.0%$151.95
37
2019-Q1
New
80,403
-
$9.6M0.0%$119.19
38

Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used